Sara Suliman, PhD, MPH
Assistant Professor
Medicine
School of Medicine

Tuberculosis (TB) disease, caused by infection with the intracellular pathogen Mycobacterium tuberculosis (Mtb) remains a leading cause of mortality globally. Interestingly, only 5-10% of Mtb-exposed individuals are estimated to develop active TB in their lifetime, thus posing host-specific factors as mediators of risk of progression to disease.

Show full bio (70 words) Hide full bio

These host factors include several defects in innate and adaptive immunity, metabolic dysregulation, co-infections and comorbidities, and genetic polymorphisms that could mediate susceptibility to TB disease. The focus of the Suliman laboratory is to generate hypotheses from systems biology approaches, such as genome-wide association studies, transcriptional and metabolomic profiling, and expression quantitative trait loci, to identify candidate TB risk pathways and functionally evaluate their roles in TB progression.

Education & Training

Show all (3) Hide

  • MPH Public Health University of Waterloo 10/2017
  • PhD Immunology University of Toronto 06/2013
  • BSc Biomedical Sciences University of Guelph 06/2006

Publications (11)

Top publication keywords:
Immunoglobulin MImmunoglobulin GMucosal-Associated Invariant T CellsTuberculosisImmunization, SecondaryMinor Histocompatibility AntigensHistocompatibility Antigens Class IBCG VaccineAntibodies, ViralFetal BloodLatent TuberculosisTuberculosis VaccinesAntitubercular AgentsMycobacterium tuberculosisIsoniazid

Show all (6 more) Hide